Literature DB >> 6359611

An ultrastructural study of enteropathogenic Escherichia coli infection in human infants.

R J Rothbaum, J C Partin, K Saalfield, A J McAdams.   

Abstract

Over the past 2 years, we have studied and treated 18 infants with protracted diarrhea due to an enteropathogenic Escherichia coli serogroup 0119. All patients had persistent stool escretion and jejunal over-growth with this pathogenic E. coli. Jejunal biopsy revealed atrophy of villi with a chronic inflammatory cell infiltrate in the lamina propria. E. coli 0119 adhered to the luminal surface of enterocytes. Electron microscopy showed disappearance of glycocalyx and microvilli at the areas of bacterial adherence. Intracellular damage was indicated by dilatation of rough endoplasmic reticulum, mitochondrial changes, and cytoplasmic pallor. Similar changes in histology and ultrastructure occurred in ileal epithelial cells. Glandular crypt epithelium showed prominent subnuclear vacuolation and separation of lateral intercellular junctions throughout the small intestine. Rectal mucosal biopsy showed mucus depletion and irregular atrophy of the epithelium, with E. coli 0119 adherent to the luminal surface. Ultrastructural damage paralleled that in the small intestine. E. coli 0119 causes damage to epithelial cells throughout the infant intestinal tract. This damage leads to atrophy of villi and a marked reduction in absorptive surface area, resulting in protracted diarrhea.

Entities:  

Mesh:

Year:  1983        PMID: 6359611     DOI: 10.3109/01913128309140582

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  43 in total

1.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens.

Authors:  R Moxon; C Tang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

3.  Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.

Authors:  M Abul-Milh; Y Wu; B Lau; C A Lingwood; D Barnett Foster
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.

Authors:  J K Crane; S Majumdar; D F Pickhardt
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  BfpB, an outer membrane lipoprotein required for the biogenesis of bundle-forming pili in enteropathogenic Escherichia coli.

Authors:  S W Ramer; D Bieber; G K Schoolnik
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

6.  Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.

Authors:  Robert K Shaw; Jennifer Cleary; Michael S Murphy; Gad Frankel; Stuart Knutton
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.

Authors:  John K Crane; Irina Shulgina; Tonniele M Naeher
Journal:  Purinergic Signal       Date:  2007-05-17       Impact factor: 3.765

8.  Feedback effects of host-derived adenosine on enteropathogenic Escherichia coli.

Authors:  John K Crane; Irina Shulgina
Journal:  FEMS Immunol Med Microbiol       Date:  2009-08-18

9.  Effect of zinc in enteropathogenic Escherichia coli infection.

Authors:  John K Crane; Tonniele M Naeher; Irina Shulgina; Chengru Zhu; Edgar C Boedeker
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

10.  Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients.

Authors:  Adilene Olvera; Hannah Carter; Anubama Rajan; Lily G Carlin; Xiaomin Yu; Xi-Lei Zeng; Samuel Shelburne; Micah Bhatti; Sarah E Blutt; Noah F Shroyer; Robert Jenq; Mary K Estes; Anthony Maresso; Pablo C Okhuysen
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.